Loading organizations...
Marathon Venture Partners is an international venture capital firm founded in 2016, with its headquarters located in Beijing, China. The firm specializes in identifying and supporting companies across both early and growth stages of development. Its investment strategy is concentrated on specific high-growth sectors, including digital health, the wider healthcare industry, and the financial technology (Fintech) sector.
Key people at Marathon Venture Partners.
Marathon Venture Partners primarily focuses its investments on companies operating within the digital health, broader healthcare, and Fintech industries.
The firm invests in both early-stage and growth-stage companies, providing capital and support across different phases of a company's development.
Marathon Venture Partners is headquartered in Beijing, China.
Marathon Venture Partners primarily focuses its investments on companies operating within the digital health, broader healthcare, and Fintech industries.
The firm invests in both early-stage and growth-stage companies, providing capital and support across different phases of a company's development.
Marathon Venture Partners is headquartered in Beijing, China.
Key people at Marathon Venture Partners.
The firm's focus on these industries allows it to target innovations and disruptive technologies within critical market segments. By engaging with companies at various stages, Marathon Venture Partners aims to provide capital and strategic support to foster their expansion and market penetration. This dual-stage investment approach enables the firm to participate in the initial development of promising startups as well as the scaling of more established ventures.
With a team size typically ranging between 11 and 50 employees, Marathon Venture Partners maintains a focused operational structure. This team is dedicated to investment management, working to identify opportunities and manage its portfolio within its specialized sectors. The firm's presence in Beijing positions it within a dynamic technological and economic hub, facilitating access to a diverse range of investment prospects.
Marathon Venture Partners' commitment to the digital health, healthcare, and Fintech industries underscores its strategy to invest in areas poised for significant transformation and growth. The firm's activities contribute to the venture ecosystem by providing essential funding and expertise to companies developing solutions in these critical sectors.
Marathon Venture Partners has 5 tracked investments across 5 companies. The latest tracked deal is Seed in Yangshan Medical Technology in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 6, 2026 | Yangshan Medical Technology | Seed | Marathon Venture Partners, Sunland Fund | BlueRun Ventures |
| Aug 26, 2021 | Shanghai Shangyong Technology | $15.4M Series C | — | — |
| Aug 17, 2021 | Meditrust | $308.7M Series C | Boyu Capital, Janchor Partners | Aihc Capital, Bank OF China Group Investment, China Everbright, China Renaissance, CICC Capital, Lake Bleu Capital, Lilly Asia Ventures, NEW Alliance Capital, Shanghai Biopharmaceutical Fund, Sinovation Ventures |
| Aug 31, 2020 | Shukun Technology | $29.2M Series B | Qiming Venture Partners | China Creation Ventures, Huagai Capital, Morningside, PuFa Silicon Valley Bank, Thundersoft |
| Aug 23, 2017 | Baozhunniu | $15.0M Series B | Marathon Venture Partners | — |
